LIP
EW icon

Lighthouse Investment Partners’s Edwards Lifesciences EW Stock Holding History

Lighthouse Investment Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-30,000
Closed -$2.1M – 546
2024
Q3 		$2.1M Buy
+30,000
New +$2.18M 0.08% 249

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Lighthouse Investment Partners's EW Position: Q1 2026 in Review

Lighthouse Investment Partners opened a new position in Edwards Lifesciences (EW) in Q1 2026: 3,148 shares worth $252K. The stake represents 0.01% of the portfolio and ranks #615 among its holdings. This is a return to the name: Lighthouse Investment Partners previously reported a position in EW as recently as Q2 2025.

Lighthouse Investment Partners first reported a position in EW in Q4 2023 and has held it in 7 quarters since. The position peaked at $9.93M in Q2 2024. 1,287 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Lighthouse Investment Partners held 3,148 shares of Edwards Lifesciences worth $252K as of Q1 2026.
  • Edwards Lifesciences was a new Lighthouse Investment Partners position in Q1 2026.
  • Edwards Lifesciences made up 0.01% of Lighthouse Investment Partners's portfolio in Q1 2026, its #615 holding.
  • Lighthouse Investment Partners first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 7 quarters since.
  • Lighthouse Investment Partners's Edwards Lifesciences position peaked at $9.93M in Q2 2024.
  • 1,287 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Lighthouse Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.